Enzymatic Debridement in Wound Care: Collagenase Guide

Enzymatic Debridement: Collagenase in Wound Care Practice

Enzymatic debridement with collagenase (brand name Santyl) is the only FDA-cleared enzymatic debrider available in the United States. Enzymatic debridement in wound care fills a specific niche: it removes nonviable tissue in wounds where sharp debridement is contraindicated, where the patient cannot tolerate a procedure, or where maintenance debridement between sharp debridement sessions is needed.

Understanding when collagenase is the right tool -- and when it is the wrong one -- prevents both clinical delays and billing complications.

How Collagenase Works

Collagenase Santyl Ointment contains clostridial collagenase, an enzyme derived from Clostridium histolyticum. The enzyme selectively breaks down denatured collagen (necrotic tissue, slough) while sparing healthy collagen in the wound bed. This selective action makes it safer than some chemical debriders, though slower than sharp or mechanical debridement.

The enzyme is active at wound pH (6.0-8.0) and requires a moist wound environment. Dry eschar or desiccated wound surfaces inactivate the enzyme. This is why cross-hatching technique exists.

Indications for Enzymatic Debridement

Use collagenase when:

The wound has slough or thin adherent necrotic tissue that is not amenable to bedside sharp debridement
The patient is anticoagulated and sharp debridement carries elevated bleeding risk
The wound is on the face, digits, or areas where sharp debridement risks structural damage
Maintenance debridement is needed between sharp debridement sessions
The patient or facility setting does not support sharp debridement (home health, SNF without trained debrider)
Palliative wound management where invasive procedures are not aligned with care goals

Do not use collagenase when:

Thick, dry eschar covers the wound -- collagenase cannot penetrate intact eschar without cross-hatching, and even with cross-hatching, thick eschar is better managed by sharp or surgical debridement
Active wound infection is present -- debride sharply and manage infection before introducing enzymatic agents
The wound bed is clean and granulating -- collagenase on healthy tissue serves no purpose and adds cost
The wound requires rapid debridement for clinical urgency (e.g., necrotizing fasciitis, deep abscess)

Cross-Hatching Technique

Cross-hatching is the technique that makes collagenase effective on eschar. Without it, the enzyme sits on the surface of intact eschar and accomplishes nothing.

Procedure

Assess the eschar. Cross-hatching is appropriate for thin-to-moderate adherent eschar. Thick, leathery eschar (>5mm) should be sharp-debrided first.
Score the eschar surface using a #15 blade or #11 blade in a crosshatch pattern -- parallel cuts approximately 5mm apart in one direction, then perpendicular cuts to create a grid. Cut through the eschar but do not penetrate into viable tissue.
Apply collagenase ointment in a thin layer (approximately 2mm thick) directly to the scored eschar and any exposed slough. The enzyme penetrates through the score lines to reach the necrotic tissue beneath.
Cover with a moisture-retentive secondary dressing -- a non-adherent contact layer followed by foam or gauze. The moist environment maintains enzyme activity.
Reapply daily or per wound care visit schedule. Collagenase is typically applied once or twice daily. Remove any loose necrotic debris at each dressing change before reapplying.

Critical Application Details

Apply collagenase in a thin, uniform layer. Thick application does not increase efficacy and wastes product.
Do not use collagenase with silver dressings, iodine, or metal-containing wound products at the wound interface. Heavy metal ions denature the enzyme.
Hydrogen peroxide, Dakin's solution, and acidic wound cleansers also inactivate collagenase. Cleanse with saline or pH-neutral wound cleanser only.
Moisture balance is essential. If the wound is dry, moisten the bed with saline before applying collagenase.

Enzymatic vs. Sharp Debridement: Decision Framework

The choice is not enzymatic OR sharp. In most wound care practices, they complement each other.

Factor	Sharp Debridement	Enzymatic Debridement
Speed	Immediate tissue removal	Days to weeks
Tissue selectivity	Operator-dependent	Enzyme-selective
Bleeding risk	Higher	Minimal
Eschar type	Thick, leathery, or adherent	Thin, sloughy, or scored
Setting	Clinic, bedside with trained clinician	Any care setting
Pain	Moderate to significant	Minimal
Reimbursement	CPT 97597/97598 or 11042-11047	Prescription cost, no procedure code

The Hybrid Approach

Many wound care clinicians use a hybrid strategy: sharp debridement to remove the bulk of necrotic tissue, followed by collagenase for maintenance debridement of residual slough between visits. This approach is clinically sound and well-supported by evidence.

The key documentation point: if you are billing for sharp or excisional debridement, the wound must have debrided tissue documented. Do not bill debridement CPT codes and simultaneously document that the wound is being managed with collagenase alone.

Billing Considerations

Collagenase is a prescription product, not a billable procedure. The clinician prescribes Santyl, and the cost is covered under the patient's pharmacy benefit (or out of pocket if not covered).

What you bill:

E/M service for the wound care visit
Debridement codes (97597/97598 or 11042-11047) ONLY if you perform sharp or selective debridement during the same visit
Do not bill active wound management codes for the act of applying collagenase alone

Documentation requirements:

Document why enzymatic debridement is appropriate for this wound at this time
Describe the wound bed, including percentage and type of nonviable tissue
If cross-hatching is performed, document the technique -- this constitutes selective debridement and may support 97597 billing depending on the tissue removed

Key Takeaways

Collagenase is the only FDA-cleared enzymatic debrider in the U.S. and fills a specific niche for wounds where sharp debridement is contraindicated or between procedures
Cross-hatching through eschar is mandatory for collagenase to penetrate and function on intact necrotic tissue
Do not combine collagenase with silver, iodine, or heavy-metal wound products -- they denature the enzyme
Enzymatic debridement is a prescription pharmacy cost, not a billable procedure code; bill E/M and debridement codes only for procedures you actually perform
Document the clinical rationale for choosing enzymatic over sharp debridement at each visit